Firalis SAS, a producer and service provider in biomarker R&D, is pleased to announce the certification of its development and production department, located in Huningue, France; according to ISO 13485:2003 and 9001:2008 standards. Certifications cover development and production of ELISA kits.
These standards specify the requirements for a comprehensive quality management system for the design and manufacture of medical devices, being the “ELISA kits” at Firalis.
This achievement represents the commitment to provide clients with the highest quality products within an environment of continuous improvement. The ISO standards guarantee a strong, additional assurance for production activities, where Firalis matches the quality standards of the market.
Click to view certificates by AFNOR:
Firalis SAS is a privately owned life sciences company, creating novel values via biomarker discovery, development and regulatory qualifications; to establish an internal portfolio of biomarker-based diagnostic methods and to provide customized biomarker solutions. Firalis is active in the field of drug safety, cardiovascular, inflammatory and autoimmune diseases. The company has been awarded with several national and international prizes and grants, for its innovative approaches and research projects.